CL

Celldex Therapeutics

- NASDAQ:CLDX
Last Updated 2024-04-23
  • Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system

  • Locations

    • Hampton NJ

  • Total Funding (USD)

    2.0 million

  • Industries

    Software, Mobile Apps, Real Estate, Cyber Security, Internet

  • Acquisitions (4)

    • Kolltan Pharmaceuticals (2016)
    • Curagen Corporation (2009)
    • Lorantis (2005)
    • Alteris Therapeutics (2005)

  • Security

    Type: ORD
    CUSIP: 15117B202
    ISIN: US15117B2025
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo